Showing results (591-600 of 615) with videos related to

Sort By:
Pageof 62
Familial Cancer|July 24, 2015
Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair geneAung Ko Win, Jeanette C Reece, Daniel D Buchanan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic AdenocarcinomaAmro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.
Surgical Endoscopy|September 22, 2022
Minimally invasive versus open hepatectomy for the resection of colorectal liver metastases: a systematic review and meta-analysisAhmad Ozair, Amelia Collings, Alexandra M Adams, et al.
Surgical Endoscopy|February 22, 2023
SAGES/AHPBA guidelines for the use of minimally invasive surgery for the surgical treatment of colorectal liver metastases (CRLM)Timothy J Vreeland, Amelia T Collings, Ahmad Ozair, et al.
Journal of Natural Products|January 24, 2020
Cryptic Species Account for the Seemingly Idiosyncratic Secondary Metabolism of Sarcophyton glaucum Specimens Collected in PalauKatherine N Maloney, Ryan T Botts, Taylor S Davis, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapyHunter C Gits, Amy H Tang, William S Harmsen, et al.
Gastroenterology|January 22, 2014
Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancerAung Ko Win, James G Dowty, Sean P Cleary, et al.
Pageof 62